CTKB

Cytek Biosciences Stock Analysis

AI Rating

Fair
  • Quality5/10
  • Growth↓ 4/10
  • Momentum↑ 5/10
Cytek Biosciences sales and earnings growth
CTKB Growth
Neutral
  • Revenue Y/Y↓ -2.18%
  • EPS Y/Y↓ -25.00%
  • FCF Y/Y↓ -120.40%
Cytek Biosciences gross and profit margin trends
CTKB Profitability
Fair
  • Gross margin ↑ 53.50%
  • EPS margin↓ -6.50%
  • ROIC↓ -3.20%
Cytek Biosciences net debt vs free cash flow
CTKB Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 0.0
  • Interest coverage↓ -1.7

Cytek Biosciences stock volatility is in-line with the overall market. We give it a Great risk rating.

More Medical Devices stocks ↗